JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |
Woodline Partners LP | 85,708 | $863,937 | 0.01% |
Citadel Advisors | 3,431,209 | $34,586,587 | 0.01% |
FMR LLC | 6,351,322 | $64,021,326 | 0.01% |
Trexquant Investment LP | 11,773 | $118,672 | 0.00% |
EXCHANGE TRADED CONCEPTS, LLC | 10,602 | $106,868 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 19,241 | $193,949 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 8,631 | $87,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 1,004 | $10,120 | 0.00% |
Ameritas Investment Partners, Inc. | 1,706 | $17,196 | 0.00% |
DekaBank Deutsche Girozentrale | 49,500 | $484 | 0.00% |
External links
This page lists JANUX THERAPEUTICS INC's shareholders in Q3 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.